View Cart  

Mexico Taking Closer Look at Clinical Trial Protocols, Investigator Sites

A A
Mexico’s drug regulator Cofepris has doubled its clinical trial protocol review timeline, with approvals coming in six months now instead of three, an expert says.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00